CymitQuimica logo

CAS 264622-53-9: N-(4-Acetylphenyl)-2-[4-(2,3,6,9-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy]acetamide

Formula:C27H29N5O5
InChI:InChI=1S/C27H29N5O5/c1-4-14-31-25-23(26(35)32(15-5-2)27(31)36)29-24(30-25)19-8-12-21(13-9-19)37-16-22(34)28-20-10-6-18(7-11-20)17(3)33/h6-13H,4-5,14-16H2,1-3H3,(H,28,34)(H,29,30)
InChI key:InChIKey=ZKUCFFYOQOJLGT-UHFFFAOYSA-N
SMILES:C(CC)N1C2=C(NC(=N2)C3=CC=C(OCC(NC4=CC=C(C(C)=O)C=C4)=O)C=C3)C(=O)N(CCC)C1=O
Synonyms:
  • Acetamide, N-(4-acetylphenyl)-2-[4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy]-
  • MRS 1706
  • Acetamide, N-(4-acetylphenyl)-2-[4-(2,3,6,9-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy]-
  • N-(4-Acetylphenyl)-2-[4-(2,3,6,9-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy]acetamide
Sort by

Found 5 products.
  • MRS 1706

    CAS:
    Formula:C27H29N5O5
    Purity:96%
    Color and Shape:Solid
    Molecular weight:503.5497

    Ref: IN-DA00C4HV

    1mg
    75.00€
    5mg
    206.00€
    10mg
    246.00€
    25mg
    696.00€
    50mg
    To inquire
    100mg
    To inquire
  • MRS 1706

    Controlled Product
    CAS:
    Formula:C27H29N5O5
    Color and Shape:Neat
    Molecular weight:503.55

    Ref: TR-M750225

    500mg
    2,358.00€
  • MRS-1706

    CAS:
    MRS-1706: Ki of 1.39nM for A2B; selective inverse agonist; also affects A2A, A1, A3.
    Formula:C27H29N5O5
    Purity:97.95%
    Color and Shape:Solid
    Molecular weight:503.55

    Ref: TM-T16136

    1mg
    37.00€
    2mg
    52.00€
    5mg
    79.00€
    10mg
    119.00€
    25mg
    240.00€
    50mg
    472.00€
    100mg
    687.00€
    1mL*10mM (DMSO)
    88.00€
  • MRS-1706

    CAS:
    MRS-1706
    Purity:≥95%
    Molecular weight:503.55g/mol

    Ref: 54-BUP09507

    1mg
    55.00€
    2mg
    70.00€
    5mg
    109.00€
    10mg
    185.00€
    25mg
    343.00€
    50mg
    659.00€
  • MRS-1706

    Controlled Product
    CAS:
    MRS-1706 is a compound that inhibits the effect of ATP on P2Y receptors. MRS-1706 has been shown to be effective in reducing inflammation and suppressing the proliferation of cells, which are associated with primary sclerosing cholangitis (PSC). The drug also has an inhibitory effect on adenosine production by affecting the mitochondrial membrane potential and Ca2+ overload. MRS-1706 can reduce camp levels, inhibit receptor activity and increase gamma-aminobutyric acid levels, leading to decreased cellular proliferation. MRS-1706 also binds to A3 adenosine receptors, which leads to a reduction in cell proliferation.
    Formula:C27H29N5O5
    Purity:Min. 95%
    Molecular weight:503.55 g/mol

    Ref: 3D-PKA62253

    50mg
    1,032.00€
    100mg
    1,353.00€